nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—CYP1A2—Estropipate—osteoporosis	0.0799	0.31	CbGbCtD
Alitretinoin—ABCB1—Ethinyl Estradiol—osteoporosis	0.045	0.175	CbGbCtD
Alitretinoin—CYP1A2—Conjugated Estrogens—osteoporosis	0.0378	0.147	CbGbCtD
Alitretinoin—CYP1A2—Estradiol—osteoporosis	0.0332	0.129	CbGbCtD
Alitretinoin—ABCB1—Conjugated Estrogens—osteoporosis	0.033	0.128	CbGbCtD
Alitretinoin—ABCB1—Estradiol—osteoporosis	0.029	0.112	CbGbCtD
Alitretinoin—RARB—Generic Transcription Pathway—ESR2—osteoporosis	0.000267	0.00108	CbGpPWpGaD
Alitretinoin—RXRA—Biological oxidations—CYP19A1—osteoporosis	0.000266	0.00108	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—TPI1—osteoporosis	0.000258	0.00105	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—TPI1—osteoporosis	0.000258	0.00105	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—ESR2—osteoporosis	0.000256	0.00104	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—ESR2—osteoporosis	0.000256	0.00104	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—RPL24—osteoporosis	0.000255	0.00103	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—RPL24—osteoporosis	0.00025	0.00101	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000249	0.00101	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—AGER—osteoporosis	0.000248	0.00101	CbGpPWpGaD
Alitretinoin—CYP1A2—Tryptophan metabolism—CYP19A1—osteoporosis	0.000243	0.000986	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—P4HB—osteoporosis	0.000243	0.000984	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—P4HB—osteoporosis	0.000243	0.000984	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000243	0.000984	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—RPL24—osteoporosis	0.000239	0.00097	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—RPL24—osteoporosis	0.000239	0.00097	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GAPDH—osteoporosis	0.000238	0.000966	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GAPDH—osteoporosis	0.000238	0.000966	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—IRS2—osteoporosis	0.000237	0.000962	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—VDR—osteoporosis	0.000237	0.000959	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—TGFB1—osteoporosis	0.000235	0.000952	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—LEP—osteoporosis	0.000232	0.000942	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—RAP1A—osteoporosis	0.000232	0.000941	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—RAP1A—osteoporosis	0.000232	0.000941	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—TGFB1—osteoporosis	0.000221	0.000895	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—TNF—osteoporosis	0.000219	0.000889	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—VDR—osteoporosis	0.000216	0.000877	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TLN1—osteoporosis	0.000214	0.000868	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—VDR—osteoporosis	0.000212	0.00086	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—ACTG1—osteoporosis	0.000211	0.000857	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000211	0.000856	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—IRS1—osteoporosis	0.000207	0.00084	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—TNF—osteoporosis	0.000206	0.000836	CbGpPWpGaD
Alitretinoin—Dyspnoea—Risedronate—osteoporosis	0.000204	0.000412	CcSEcCtD
Alitretinoin—Erythema multiforme—Estradiol—osteoporosis	0.000204	0.000411	CcSEcCtD
Alitretinoin—RARA—Generic Transcription Pathway—VDR—osteoporosis	0.000203	0.000824	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—VDR—osteoporosis	0.000203	0.000824	CbGpPWpGaD
Alitretinoin—Hypotension—Pamidronate—osteoporosis	0.000203	0.00041	CcSEcCtD
Alitretinoin—Convulsion—Conjugated Estrogens—osteoporosis	0.000203	0.00041	CcSEcCtD
Alitretinoin—Dry mouth—Zoledronate—osteoporosis	0.000203	0.000409	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000203	0.000409	CcSEcCtD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000202	0.00082	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000202	0.00082	CbGpPWpGaD
Alitretinoin—Fatigue—Ethinyl Estradiol—osteoporosis	0.000202	0.000408	CcSEcCtD
Alitretinoin—Pruritus—Alendronate—osteoporosis	0.000202	0.000407	CcSEcCtD
Alitretinoin—Dyspepsia—Risedronate—osteoporosis	0.000201	0.000407	CcSEcCtD
Alitretinoin—Eye disorder—Estradiol—osteoporosis	0.000201	0.000407	CcSEcCtD
Alitretinoin—Tinnitus—Estradiol—osteoporosis	0.000201	0.000406	CcSEcCtD
Alitretinoin—Constipation—Ethinyl Estradiol—osteoporosis	0.000201	0.000405	CcSEcCtD
Alitretinoin—Confusional state—Zoledronate—osteoporosis	0.0002	0.000404	CcSEcCtD
Alitretinoin—Hypersensitivity—Calcitriol—osteoporosis	0.0002	0.000404	CcSEcCtD
Alitretinoin—Flushing—Estradiol—osteoporosis	0.0002	0.000404	CcSEcCtD
Alitretinoin—Chest pain—Conjugated Estrogens—osteoporosis	0.0002	0.000403	CcSEcCtD
Alitretinoin—Myalgia—Conjugated Estrogens—osteoporosis	0.0002	0.000403	CcSEcCtD
Alitretinoin—Arthralgia—Conjugated Estrogens—osteoporosis	0.0002	0.000403	CcSEcCtD
Alitretinoin—Asthenia—Ibandronate—osteoporosis	0.000199	0.000402	CcSEcCtD
Alitretinoin—Anxiety—Conjugated Estrogens—osteoporosis	0.000199	0.000401	CcSEcCtD
Alitretinoin—Nausea—Etidronic acid—osteoporosis	0.000199	0.000401	CcSEcCtD
Alitretinoin—Anaphylactic shock—Zoledronate—osteoporosis	0.000199	0.000401	CcSEcCtD
Alitretinoin—Oedema—Zoledronate—osteoporosis	0.000199	0.000401	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000198	0.0004	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000198	0.0004	CcSEcCtD
Alitretinoin—Diarrhoea—Estropipate—osteoporosis	0.000198	0.0004	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Risedronate—osteoporosis	0.000198	0.000399	CcSEcCtD
Alitretinoin—Infection—Zoledronate—osteoporosis	0.000197	0.000398	CcSEcCtD
Alitretinoin—Fatigue—Risedronate—osteoporosis	0.000197	0.000398	CcSEcCtD
Alitretinoin—Insomnia—Pamidronate—osteoporosis	0.000197	0.000397	CcSEcCtD
Alitretinoin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000197	0.000797	CbGpPWpGaD
Alitretinoin—Pruritus—Ibandronate—osteoporosis	0.000196	0.000397	CcSEcCtD
Alitretinoin—Constipation—Risedronate—osteoporosis	0.000196	0.000395	CcSEcCtD
Alitretinoin—Pain—Risedronate—osteoporosis	0.000196	0.000395	CcSEcCtD
Alitretinoin—Angiopathy—Estradiol—osteoporosis	0.000196	0.000395	CcSEcCtD
Alitretinoin—Shock—Zoledronate—osteoporosis	0.000195	0.000395	CcSEcCtD
Alitretinoin—Paraesthesia—Pamidronate—osteoporosis	0.000195	0.000394	CcSEcCtD
Alitretinoin—Diarrhoea—Alendronate—osteoporosis	0.000195	0.000394	CcSEcCtD
Alitretinoin—Asthenia—Calcitriol—osteoporosis	0.000195	0.000394	CcSEcCtD
Alitretinoin—Nervous system disorder—Zoledronate—osteoporosis	0.000195	0.000393	CcSEcCtD
Alitretinoin—Thrombocytopenia—Zoledronate—osteoporosis	0.000195	0.000393	CcSEcCtD
Alitretinoin—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000194	0.000787	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000194	0.000786	CbGpPWpGaD
Alitretinoin—Dyspnoea—Pamidronate—osteoporosis	0.000194	0.000391	CcSEcCtD
Alitretinoin—Tachycardia—Zoledronate—osteoporosis	0.000194	0.000391	CcSEcCtD
Alitretinoin—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000193	0.00039	CcSEcCtD
Alitretinoin—Chills—Estradiol—osteoporosis	0.000193	0.00039	CcSEcCtD
Alitretinoin—Somnolence—Pamidronate—osteoporosis	0.000193	0.00039	CcSEcCtD
Alitretinoin—Skin disorder—Zoledronate—osteoporosis	0.000193	0.00039	CcSEcCtD
Alitretinoin—Pruritus—Calcitriol—osteoporosis	0.000192	0.000388	CcSEcCtD
Alitretinoin—Hyperhidrosis—Zoledronate—osteoporosis	0.000192	0.000388	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—IGF1—osteoporosis	0.000192	0.000778	CbGpPWpGaD
Alitretinoin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000192	0.000387	CcSEcCtD
Alitretinoin—Diarrhoea—Raloxifene—osteoporosis	0.000192	0.000387	CcSEcCtD
Alitretinoin—Dyspepsia—Pamidronate—osteoporosis	0.000191	0.000387	CcSEcCtD
Alitretinoin—Dizziness—Estropipate—osteoporosis	0.000191	0.000387	CcSEcCtD
Alitretinoin—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000191	0.000386	CcSEcCtD
Alitretinoin—Oedema—Conjugated Estrogens—osteoporosis	0.000191	0.000386	CcSEcCtD
Alitretinoin—Alopecia—Estradiol—osteoporosis	0.00019	0.000384	CcSEcCtD
Alitretinoin—Infection—Conjugated Estrogens—osteoporosis	0.00019	0.000384	CcSEcCtD
Alitretinoin—Diarrhoea—Ibandronate—osteoporosis	0.00019	0.000383	CcSEcCtD
Alitretinoin—Anorexia—Zoledronate—osteoporosis	0.000189	0.000382	CcSEcCtD
Alitretinoin—Decreased appetite—Pamidronate—osteoporosis	0.000189	0.000382	CcSEcCtD
Alitretinoin—Mental disorder—Estradiol—osteoporosis	0.000189	0.000381	CcSEcCtD
Alitretinoin—Dizziness—Alendronate—osteoporosis	0.000189	0.000381	CcSEcCtD
Alitretinoin—Shock—Conjugated Estrogens—osteoporosis	0.000188	0.00038	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000188	0.000379	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—ENO1—osteoporosis	0.000188	0.00076	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—ENO1—osteoporosis	0.000188	0.00076	CbGpPWpGaD
Alitretinoin—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000188	0.000379	CcSEcCtD
Alitretinoin—Erythema—Estradiol—osteoporosis	0.000188	0.000379	CcSEcCtD
Alitretinoin—Malnutrition—Estradiol—osteoporosis	0.000188	0.000379	CcSEcCtD
Alitretinoin—Fatigue—Pamidronate—osteoporosis	0.000188	0.000379	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Risedronate—osteoporosis	0.000187	0.000378	CcSEcCtD
Alitretinoin—Tachycardia—Conjugated Estrogens—osteoporosis	0.000187	0.000377	CcSEcCtD
Alitretinoin—Urticaria—Ethinyl Estradiol—osteoporosis	0.000186	0.000376	CcSEcCtD
Alitretinoin—Constipation—Pamidronate—osteoporosis	0.000186	0.000375	CcSEcCtD
Alitretinoin—Pain—Pamidronate—osteoporosis	0.000186	0.000375	CcSEcCtD
Alitretinoin—Diarrhoea—Calcitriol—osteoporosis	0.000186	0.000375	CcSEcCtD
Alitretinoin—Skin disorder—Conjugated Estrogens—osteoporosis	0.000186	0.000375	CcSEcCtD
Alitretinoin—Hypotension—Zoledronate—osteoporosis	0.000186	0.000375	CcSEcCtD
Alitretinoin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000186	0.000375	CcSEcCtD
Alitretinoin—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000186	0.000375	CcSEcCtD
Alitretinoin—Dizziness—Raloxifene—osteoporosis	0.000185	0.000374	CcSEcCtD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—GPX1—osteoporosis	0.000185	0.000751	CbGpPWpGaD
Alitretinoin—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000185	0.000373	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—PSMA5—osteoporosis	0.000185	0.000749	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PSMA2—osteoporosis	0.000185	0.000749	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PSMA2—osteoporosis	0.000185	0.000749	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PSMA5—osteoporosis	0.000185	0.000749	CbGpPWpGaD
Alitretinoin—Flatulence—Estradiol—osteoporosis	0.000185	0.000373	CcSEcCtD
Alitretinoin—Tension—Estradiol—osteoporosis	0.000184	0.000372	CcSEcCtD
Alitretinoin—Vomiting—Estropipate—osteoporosis	0.000184	0.000372	CcSEcCtD
Alitretinoin—Dizziness—Ibandronate—osteoporosis	0.000184	0.000371	CcSEcCtD
Alitretinoin—Rash—Estropipate—osteoporosis	0.000183	0.000369	CcSEcCtD
Alitretinoin—Dermatitis—Estropipate—osteoporosis	0.000182	0.000368	CcSEcCtD
Alitretinoin—Anorexia—Conjugated Estrogens—osteoporosis	0.000182	0.000368	CcSEcCtD
Alitretinoin—Nervousness—Estradiol—osteoporosis	0.000182	0.000368	CcSEcCtD
Alitretinoin—Urticaria—Risedronate—osteoporosis	0.000182	0.000367	CcSEcCtD
Alitretinoin—Back pain—Estradiol—osteoporosis	0.000181	0.000366	CcSEcCtD
Alitretinoin—Headache—Estropipate—osteoporosis	0.000181	0.000366	CcSEcCtD
Alitretinoin—Vomiting—Alendronate—osteoporosis	0.000181	0.000366	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000181	0.000365	CcSEcCtD
Alitretinoin—Abdominal pain—Risedronate—osteoporosis	0.000181	0.000365	CcSEcCtD
Alitretinoin—Body temperature increased—Risedronate—osteoporosis	0.000181	0.000365	CcSEcCtD
Alitretinoin—RARG—Generic Transcription Pathway—ESR1—osteoporosis	0.000181	0.000732	CbGpPWpGaD
Alitretinoin—Rash—Alendronate—osteoporosis	0.00018	0.000363	CcSEcCtD
Alitretinoin—Insomnia—Zoledronate—osteoporosis	0.00018	0.000363	CcSEcCtD
Alitretinoin—Dermatitis—Alendronate—osteoporosis	0.00018	0.000363	CcSEcCtD
Alitretinoin—Feeling abnormal—Pamidronate—osteoporosis	0.000179	0.000362	CcSEcCtD
Alitretinoin—Hypotension—Conjugated Estrogens—osteoporosis	0.000179	0.000361	CcSEcCtD
Alitretinoin—Headache—Alendronate—osteoporosis	0.000179	0.000361	CcSEcCtD
Alitretinoin—Paraesthesia—Zoledronate—osteoporosis	0.000178	0.00036	CcSEcCtD
Alitretinoin—Vomiting—Raloxifene—osteoporosis	0.000178	0.00036	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Pamidronate—osteoporosis	0.000178	0.000359	CcSEcCtD
Alitretinoin—Dyspnoea—Zoledronate—osteoporosis	0.000177	0.000358	CcSEcCtD
Alitretinoin—RXRG—Adipogenesis—IL6—osteoporosis	0.000177	0.000717	CbGpPWpGaD
Alitretinoin—Rash—Raloxifene—osteoporosis	0.000177	0.000357	CcSEcCtD
Alitretinoin—Dermatitis—Raloxifene—osteoporosis	0.000177	0.000357	CcSEcCtD
Alitretinoin—Somnolence—Zoledronate—osteoporosis	0.000177	0.000357	CcSEcCtD
Alitretinoin—Vomiting—Ibandronate—osteoporosis	0.000177	0.000356	CcSEcCtD
Alitretinoin—Tremor—Estradiol—osteoporosis	0.000176	0.000355	CcSEcCtD
Alitretinoin—Headache—Raloxifene—osteoporosis	0.000176	0.000355	CcSEcCtD
Alitretinoin—Rash—Ibandronate—osteoporosis	0.000175	0.000353	CcSEcCtD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—osteoporosis	0.000175	0.000709	CbGpPWpGaD
Alitretinoin—Dermatitis—Ibandronate—osteoporosis	0.000175	0.000353	CcSEcCtD
Alitretinoin—Dyspepsia—Zoledronate—osteoporosis	0.000175	0.000353	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000174	0.000352	CcSEcCtD
Alitretinoin—Ill-defined disorder—Estradiol—osteoporosis	0.000174	0.000351	CcSEcCtD
Alitretinoin—Headache—Ibandronate—osteoporosis	0.000174	0.000351	CcSEcCtD
Alitretinoin—Insomnia—Conjugated Estrogens—osteoporosis	0.000173	0.000349	CcSEcCtD
Alitretinoin—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000173	0.000349	CcSEcCtD
Alitretinoin—Vomiting—Calcitriol—osteoporosis	0.000173	0.000349	CcSEcCtD
Alitretinoin—Decreased appetite—Zoledronate—osteoporosis	0.000173	0.000349	CcSEcCtD
Alitretinoin—Agitation—Estradiol—osteoporosis	0.000172	0.000348	CcSEcCtD
Alitretinoin—Nausea—Estropipate—osteoporosis	0.000172	0.000347	CcSEcCtD
Alitretinoin—Abdominal pain—Pamidronate—osteoporosis	0.000172	0.000347	CcSEcCtD
Alitretinoin—Body temperature increased—Pamidronate—osteoporosis	0.000172	0.000347	CcSEcCtD
Alitretinoin—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000172	0.000347	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000172	0.000346	CcSEcCtD
Alitretinoin—Rash—Calcitriol—osteoporosis	0.000171	0.000346	CcSEcCtD
Alitretinoin—Fatigue—Zoledronate—osteoporosis	0.000171	0.000346	CcSEcCtD
Alitretinoin—Dermatitis—Calcitriol—osteoporosis	0.000171	0.000346	CcSEcCtD
Alitretinoin—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000171	0.000344	CcSEcCtD
Alitretinoin—Headache—Calcitriol—osteoporosis	0.00017	0.000344	CcSEcCtD
Alitretinoin—Somnolence—Conjugated Estrogens—osteoporosis	0.00017	0.000343	CcSEcCtD
Alitretinoin—Constipation—Zoledronate—osteoporosis	0.00017	0.000343	CcSEcCtD
Alitretinoin—Pain—Zoledronate—osteoporosis	0.00017	0.000343	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.00017	0.000688	CbGpPWpGaD
Alitretinoin—Nausea—Alendronate—osteoporosis	0.000169	0.000342	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000169	0.000686	CbGpPWpGaD
Alitretinoin—Malaise—Estradiol—osteoporosis	0.000169	0.000342	CcSEcCtD
Alitretinoin—Hypersensitivity—Risedronate—osteoporosis	0.000169	0.00034	CcSEcCtD
Alitretinoin—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000168	0.00034	CcSEcCtD
Alitretinoin—Asthenia—Ethinyl Estradiol—osteoporosis	0.000168	0.00034	CcSEcCtD
Alitretinoin—Syncope—Estradiol—osteoporosis	0.000168	0.00034	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—U2AF1—osteoporosis	0.000168	0.00068	CbGpPWpGaD
Alitretinoin—Nausea—Raloxifene—osteoporosis	0.000167	0.000336	CcSEcCtD
Alitretinoin—RARA—Adipogenesis—IL6—osteoporosis	0.000166	0.000674	CbGpPWpGaD
Alitretinoin—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000166	0.000336	CcSEcCtD
Alitretinoin—Pruritus—Ethinyl Estradiol—osteoporosis	0.000166	0.000335	CcSEcCtD
Alitretinoin—Palpitations—Estradiol—osteoporosis	0.000166	0.000335	CcSEcCtD
Alitretinoin—RXRG—Generic Transcription Pathway—ESR1—osteoporosis	0.000165	0.00067	CbGpPWpGaD
Alitretinoin—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000165	0.000333	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000165	0.000669	CbGpPWpGaD
Alitretinoin—Fatigue—Conjugated Estrogens—osteoporosis	0.000165	0.000333	CcSEcCtD
Alitretinoin—Nausea—Ibandronate—osteoporosis	0.000165	0.000333	CcSEcCtD
Alitretinoin—Loss of consciousness—Estradiol—osteoporosis	0.000165	0.000333	CcSEcCtD
Alitretinoin—RXRA—Developmental Biology—WNT1—osteoporosis	0.000165	0.000667	CbGpPWpGaD
Alitretinoin—Asthenia—Risedronate—osteoporosis	0.000164	0.000331	CcSEcCtD
Alitretinoin—Feeling abnormal—Zoledronate—osteoporosis	0.000164	0.000331	CcSEcCtD
Alitretinoin—Cough—Estradiol—osteoporosis	0.000164	0.00033	CcSEcCtD
Alitretinoin—Constipation—Conjugated Estrogens—osteoporosis	0.000164	0.00033	CcSEcCtD
Alitretinoin—Pain—Conjugated Estrogens—osteoporosis	0.000164	0.00033	CcSEcCtD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—osteoporosis	0.000163	0.000662	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000163	0.000661	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000163	0.00066	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	0.000163	0.000658	CbGpPWpGaD
Alitretinoin—Gastrointestinal pain—Zoledronate—osteoporosis	0.000162	0.000328	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000162	0.000658	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—ESR1—osteoporosis	0.000162	0.000657	CbGpPWpGaD
Alitretinoin—Hypertension—Estradiol—osteoporosis	0.000162	0.000327	CcSEcCtD
Alitretinoin—Pruritus—Risedronate—osteoporosis	0.000162	0.000327	CcSEcCtD
Alitretinoin—Nausea—Calcitriol—osteoporosis	0.000161	0.000326	CcSEcCtD
Alitretinoin—CYP1A2—Biological oxidations—CYP27A1—osteoporosis	0.000161	0.000653	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—PSMA2—osteoporosis	0.000161	0.000651	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—PSMA5—osteoporosis	0.000161	0.000651	CbGpPWpGaD
Alitretinoin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000161	0.000324	CcSEcCtD
Alitretinoin—Hypersensitivity—Pamidronate—osteoporosis	0.00016	0.000324	CcSEcCtD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	0.00016	0.000647	CbGpPWpGaD
Alitretinoin—Arthralgia—Estradiol—osteoporosis	0.00016	0.000322	CcSEcCtD
Alitretinoin—Myalgia—Estradiol—osteoporosis	0.00016	0.000322	CcSEcCtD
Alitretinoin—Chest pain—Estradiol—osteoporosis	0.00016	0.000322	CcSEcCtD
Alitretinoin—RXRA—Biological oxidations—POMC—osteoporosis	0.00016	0.000647	CbGpPWpGaD
Alitretinoin—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000159	0.000646	CbGpPWpGaD
Alitretinoin—Anxiety—Estradiol—osteoporosis	0.000159	0.000321	CcSEcCtD
Alitretinoin—CYP1A2—Metapathway biotransformation—CYP27A1—osteoporosis	0.000159	0.000644	CbGpPWpGaD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000159	0.00032	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000158	0.000641	CbGpPWpGaD
Alitretinoin—Urticaria—Zoledronate—osteoporosis	0.000158	0.000319	CcSEcCtD
Alitretinoin—Discomfort—Estradiol—osteoporosis	0.000158	0.000319	CcSEcCtD
Alitretinoin—Abdominal pain—Zoledronate—osteoporosis	0.000157	0.000317	CcSEcCtD
Alitretinoin—Body temperature increased—Zoledronate—osteoporosis	0.000157	0.000317	CcSEcCtD
Alitretinoin—Diarrhoea—Risedronate—osteoporosis	0.000157	0.000316	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000156	0.000316	CcSEcCtD
Alitretinoin—Dry mouth—Estradiol—osteoporosis	0.000156	0.000315	CcSEcCtD
Alitretinoin—Asthenia—Pamidronate—osteoporosis	0.000156	0.000315	CcSEcCtD
Alitretinoin—RARA—Generic Transcription Pathway—ESR1—osteoporosis	0.000155	0.00063	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—ESR1—osteoporosis	0.000155	0.00063	CbGpPWpGaD
Alitretinoin—Dizziness—Ethinyl Estradiol—osteoporosis	0.000155	0.000313	CcSEcCtD
Alitretinoin—Confusional state—Estradiol—osteoporosis	0.000154	0.000312	CcSEcCtD
Alitretinoin—Pruritus—Pamidronate—osteoporosis	0.000154	0.000311	CcSEcCtD
Alitretinoin—Oedema—Estradiol—osteoporosis	0.000153	0.000309	CcSEcCtD
Alitretinoin—Anaphylactic shock—Estradiol—osteoporosis	0.000153	0.000309	CcSEcCtD
Alitretinoin—Infection—Estradiol—osteoporosis	0.000152	0.000307	CcSEcCtD
Alitretinoin—Urticaria—Conjugated Estrogens—osteoporosis	0.000152	0.000307	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000152	0.000614	CbGpPWpGaD
Alitretinoin—Dizziness—Risedronate—osteoporosis	0.000151	0.000305	CcSEcCtD
Alitretinoin—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000151	0.000305	CcSEcCtD
Alitretinoin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000151	0.000305	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000151	0.000612	CbGpPWpGaD
Alitretinoin—Shock—Estradiol—osteoporosis	0.000151	0.000304	CcSEcCtD
Alitretinoin—RXRA—Metabolism—FDPS—osteoporosis	0.000151	0.00061	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PKM—osteoporosis	0.000151	0.00061	CbGpPWpGaD
Alitretinoin—Nervous system disorder—Estradiol—osteoporosis	0.00015	0.000303	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—CYP19A1—osteoporosis	0.00015	0.000608	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—CYP19A1—osteoporosis	0.00015	0.000608	CbGpPWpGaD
Alitretinoin—Tachycardia—Estradiol—osteoporosis	0.000149	0.000302	CcSEcCtD
Alitretinoin—Vomiting—Ethinyl Estradiol—osteoporosis	0.000149	0.000301	CcSEcCtD
Alitretinoin—Diarrhoea—Pamidronate—osteoporosis	0.000149	0.0003	CcSEcCtD
Alitretinoin—Skin disorder—Estradiol—osteoporosis	0.000149	0.0003	CcSEcCtD
Alitretinoin—Hyperhidrosis—Estradiol—osteoporosis	0.000148	0.000299	CcSEcCtD
Alitretinoin—Rash—Ethinyl Estradiol—osteoporosis	0.000148	0.000299	CcSEcCtD
Alitretinoin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000148	0.000298	CcSEcCtD
Alitretinoin—Headache—Ethinyl Estradiol—osteoporosis	0.000147	0.000297	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—PSMA5—osteoporosis	0.000147	0.000595	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—PSMA2—osteoporosis	0.000147	0.000595	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Zoledronate—osteoporosis	0.000146	0.000296	CcSEcCtD
Alitretinoin—Vomiting—Risedronate—osteoporosis	0.000145	0.000294	CcSEcCtD
Alitretinoin—Rash—Risedronate—osteoporosis	0.000144	0.000291	CcSEcCtD
Alitretinoin—Dermatitis—Risedronate—osteoporosis	0.000144	0.000291	CcSEcCtD
Alitretinoin—RARB—Gene Expression—PSMA5—osteoporosis	0.000144	0.000584	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—PSMA2—osteoporosis	0.000144	0.000584	CbGpPWpGaD
Alitretinoin—Dizziness—Pamidronate—osteoporosis	0.000144	0.00029	CcSEcCtD
Alitretinoin—RARG—Gene Expression—ESR2—osteoporosis	0.000144	0.000581	CbGpPWpGaD
Alitretinoin—Headache—Risedronate—osteoporosis	0.000143	0.000289	CcSEcCtD
Alitretinoin—RXRA—Metabolism—PGLS—osteoporosis	0.000143	0.000578	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GPD2—osteoporosis	0.000143	0.000578	CbGpPWpGaD
Alitretinoin—Asthenia—Zoledronate—osteoporosis	0.000143	0.000288	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000141	0.000572	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000141	0.000285	CcSEcCtD
Alitretinoin—Pruritus—Zoledronate—osteoporosis	0.000141	0.000284	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Estradiol—osteoporosis	0.00014	0.000282	CcSEcCtD
Alitretinoin—Nausea—Ethinyl Estradiol—osteoporosis	0.000139	0.000281	CcSEcCtD
Alitretinoin—Insomnia—Estradiol—osteoporosis	0.000138	0.00028	CcSEcCtD
Alitretinoin—Vomiting—Pamidronate—osteoporosis	0.000138	0.000279	CcSEcCtD
Alitretinoin—RXRB—Gene Expression—PSMA5—osteoporosis	0.000138	0.00056	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—PSMA2—osteoporosis	0.000138	0.00056	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—PSMA2—osteoporosis	0.000138	0.00056	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—PSMA5—osteoporosis	0.000138	0.00056	CbGpPWpGaD
Alitretinoin—Paraesthesia—Estradiol—osteoporosis	0.000137	0.000278	CcSEcCtD
Alitretinoin—Asthenia—Conjugated Estrogens—osteoporosis	0.000137	0.000277	CcSEcCtD
Alitretinoin—Rash—Pamidronate—osteoporosis	0.000137	0.000277	CcSEcCtD
Alitretinoin—Dermatitis—Pamidronate—osteoporosis	0.000137	0.000277	CcSEcCtD
Alitretinoin—Dyspnoea—Estradiol—osteoporosis	0.000137	0.000276	CcSEcCtD
Alitretinoin—Headache—Pamidronate—osteoporosis	0.000136	0.000275	CcSEcCtD
Alitretinoin—Somnolence—Estradiol—osteoporosis	0.000136	0.000275	CcSEcCtD
Alitretinoin—Diarrhoea—Zoledronate—osteoporosis	0.000136	0.000274	CcSEcCtD
Alitretinoin—Nausea—Risedronate—osteoporosis	0.000136	0.000274	CcSEcCtD
Alitretinoin—Pruritus—Conjugated Estrogens—osteoporosis	0.000135	0.000273	CcSEcCtD
Alitretinoin—Dyspepsia—Estradiol—osteoporosis	0.000135	0.000272	CcSEcCtD
Alitretinoin—RXRA—Generic Transcription Pathway—ESR2—osteoporosis	0.000134	0.000541	CbGpPWpGaD
Alitretinoin—Decreased appetite—Estradiol—osteoporosis	0.000133	0.000269	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Estradiol—osteoporosis	0.000132	0.000267	CcSEcCtD
Alitretinoin—Fatigue—Estradiol—osteoporosis	0.000132	0.000266	CcSEcCtD
Alitretinoin—Dizziness—Zoledronate—osteoporosis	0.000131	0.000265	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—ESR2—osteoporosis	0.000131	0.000532	CbGpPWpGaD
Alitretinoin—Pain—Estradiol—osteoporosis	0.000131	0.000264	CcSEcCtD
Alitretinoin—Constipation—Estradiol—osteoporosis	0.000131	0.000264	CcSEcCtD
Alitretinoin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000131	0.000264	CcSEcCtD
Alitretinoin—RXRA—Metabolism—PNP—osteoporosis	0.000131	0.000529	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ATIC—osteoporosis	0.000131	0.000529	CbGpPWpGaD
Alitretinoin—Nausea—Pamidronate—osteoporosis	0.000129	0.000261	CcSEcCtD
Alitretinoin—RARB—Gene Expression—ESR2—osteoporosis	0.000129	0.000522	CbGpPWpGaD
Alitretinoin—Dizziness—Conjugated Estrogens—osteoporosis	0.000127	0.000255	CcSEcCtD
Alitretinoin—Vomiting—Zoledronate—osteoporosis	0.000126	0.000255	CcSEcCtD
Alitretinoin—Feeling abnormal—Estradiol—osteoporosis	0.000126	0.000255	CcSEcCtD
Alitretinoin—Rash—Zoledronate—osteoporosis	0.000125	0.000253	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Estradiol—osteoporosis	0.000125	0.000253	CcSEcCtD
Alitretinoin—Dermatitis—Zoledronate—osteoporosis	0.000125	0.000253	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—RPL24—osteoporosis	0.000125	0.000505	CbGpPWpGaD
Alitretinoin—Headache—Zoledronate—osteoporosis	0.000124	0.000251	CcSEcCtD
Alitretinoin—RXRB—Gene Expression—ESR2—osteoporosis	0.000123	0.0005	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—ESR2—osteoporosis	0.000123	0.0005	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—ADCY5—osteoporosis	0.000123	0.000497	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—ADCY5—osteoporosis	0.000123	0.000497	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GPX1—osteoporosis	0.000122	0.000495	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GPX1—osteoporosis	0.000122	0.000495	CbGpPWpGaD
Alitretinoin—Vomiting—Conjugated Estrogens—osteoporosis	0.000122	0.000246	CcSEcCtD
Alitretinoin—Urticaria—Estradiol—osteoporosis	0.000122	0.000246	CcSEcCtD
Alitretinoin—Body temperature increased—Estradiol—osteoporosis	0.000121	0.000244	CcSEcCtD
Alitretinoin—Abdominal pain—Estradiol—osteoporosis	0.000121	0.000244	CcSEcCtD
Alitretinoin—Rash—Conjugated Estrogens—osteoporosis	0.000121	0.000244	CcSEcCtD
Alitretinoin—Dermatitis—Conjugated Estrogens—osteoporosis	0.000121	0.000243	CcSEcCtD
Alitretinoin—Headache—Conjugated Estrogens—osteoporosis	0.00012	0.000242	CcSEcCtD
Alitretinoin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000118	0.000479	CbGpPWpGaD
Alitretinoin—Nausea—Zoledronate—osteoporosis	0.000118	0.000238	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—TGFB1—osteoporosis	0.000115	0.000466	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—VDR—osteoporosis	0.000114	0.000462	CbGpPWpGaD
Alitretinoin—Nausea—Conjugated Estrogens—osteoporosis	0.000114	0.000229	CcSEcCtD
Alitretinoin—Hypersensitivity—Estradiol—osteoporosis	0.000113	0.000228	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—MTHFR—osteoporosis	0.000113	0.000457	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—MTHFR—osteoporosis	0.000113	0.000457	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—OXCT1—osteoporosis	0.000111	0.00045	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CA2—osteoporosis	0.000111	0.00045	CbGpPWpGaD
Alitretinoin—Asthenia—Estradiol—osteoporosis	0.00011	0.000222	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	0.000109	0.00044	CbGpPWpGaD
Alitretinoin—Pruritus—Estradiol—osteoporosis	0.000108	0.000219	CcSEcCtD
Alitretinoin—RXRA—Metabolism—MGLL—osteoporosis	0.000108	0.000438	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000108	0.000437	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—TNF—osteoporosis	0.000108	0.000436	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000107	0.000435	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—VDR—osteoporosis	0.000106	0.00043	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—TGFB1—osteoporosis	0.000105	0.000425	CbGpPWpGaD
Alitretinoin—Diarrhoea—Estradiol—osteoporosis	0.000105	0.000211	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—VDR—osteoporosis	0.000104	0.000422	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000102	0.000414	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—VDR—osteoporosis	0.000102	0.000414	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000102	0.000413	CbGpPWpGaD
Alitretinoin—Dizziness—Estradiol—osteoporosis	0.000101	0.000204	CcSEcCtD
Alitretinoin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	0.000101	0.000408	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—VDR—osteoporosis	9.8e-05	0.000397	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—VDR—osteoporosis	9.8e-05	0.000397	CbGpPWpGaD
Alitretinoin—Vomiting—Estradiol—osteoporosis	9.74e-05	0.000197	CcSEcCtD
Alitretinoin—Rash—Estradiol—osteoporosis	9.65e-05	0.000195	CcSEcCtD
Alitretinoin—Dermatitis—Estradiol—osteoporosis	9.65e-05	0.000195	CcSEcCtD
Alitretinoin—Headache—Estradiol—osteoporosis	9.59e-05	0.000194	CcSEcCtD
Alitretinoin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.58e-05	0.000388	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—MYC—osteoporosis	9.4e-05	0.000381	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—IDH2—osteoporosis	9.19e-05	0.000373	CbGpPWpGaD
Alitretinoin—Nausea—Estradiol—osteoporosis	9.1e-05	0.000184	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—POMC—osteoporosis	9.02e-05	0.000365	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—POMC—osteoporosis	9.02e-05	0.000365	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL1B—osteoporosis	8.82e-05	0.000357	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—ESR1—osteoporosis	8.7e-05	0.000353	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—IL6—osteoporosis	8.68e-05	0.000351	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP27A1—osteoporosis	8.64e-05	0.00035	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—MYC—osteoporosis	8.6e-05	0.000348	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	8.48e-05	0.000344	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	8.47e-05	0.000343	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	8.46e-05	0.000343	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	8.45e-05	0.000342	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	8.44e-05	0.000342	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—MYC—osteoporosis	8.43e-05	0.000342	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	8.43e-05	0.000342	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ACP5—osteoporosis	8.41e-05	0.000341	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	8.36e-05	0.000339	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	8.3e-05	0.000336	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—ESR1—osteoporosis	8.1e-05	0.000328	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—MYC—osteoporosis	8.09e-05	0.000328	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—MYC—osteoporosis	8.09e-05	0.000328	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—LEP—osteoporosis	7.99e-05	0.000324	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—ESR1—osteoporosis	7.96e-05	0.000323	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	7.95e-05	0.000322	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ADCY5—osteoporosis	7.92e-05	0.000321	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	7.9e-05	0.00032	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	7.87e-05	0.000319	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	7.87e-05	0.000319	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—TPI1—osteoporosis	7.82e-05	0.000317	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—ESR1—osteoporosis	7.81e-05	0.000316	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	7.75e-05	0.000314	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—ESR1—osteoporosis	7.48e-05	0.000303	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—ESR1—osteoporosis	7.48e-05	0.000303	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—P4HB—osteoporosis	7.35e-05	0.000298	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GAPDH—osteoporosis	7.22e-05	0.000292	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PSMA2—osteoporosis	7.2e-05	0.000292	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PSMA5—osteoporosis	7.2e-05	0.000292	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—RAP1A—osteoporosis	7.03e-05	0.000285	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—TGFB1—osteoporosis	6.85e-05	0.000278	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—IL6R—osteoporosis	6.69e-05	0.000271	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	6.52e-05	0.000264	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—ESR2—osteoporosis	6.43e-05	0.000261	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—TNF—osteoporosis	6.4e-05	0.000259	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	6.19e-05	0.000251	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.13e-05	0.000248	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PKM—osteoporosis	6.02e-05	0.000244	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—FDPS—osteoporosis	6.02e-05	0.000244	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PGLS—osteoporosis	5.7e-05	0.000231	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GPD2—osteoporosis	5.7e-05	0.000231	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ENO1—osteoporosis	5.68e-05	0.00023	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	5.64e-05	0.000229	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PSMA5—osteoporosis	5.6e-05	0.000227	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PSMA2—osteoporosis	5.6e-05	0.000227	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	5.27e-05	0.000213	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ATIC—osteoporosis	5.22e-05	0.000211	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PNP—osteoporosis	5.22e-05	0.000211	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—VDR—osteoporosis	5.1e-05	0.000207	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—POMC—osteoporosis	5.09e-05	0.000206	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PKM—osteoporosis	4.8e-05	0.000195	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—FDPS—osteoporosis	4.8e-05	0.000195	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GPD2—osteoporosis	4.55e-05	0.000184	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PGLS—osteoporosis	4.55e-05	0.000184	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP19A1—osteoporosis	4.54e-05	0.000184	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—MYC—osteoporosis	4.53e-05	0.000183	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—OXCT1—osteoporosis	4.43e-05	0.00018	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CA2—osteoporosis	4.43e-05	0.00018	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—MGLL—osteoporosis	4.32e-05	0.000175	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—MYC—osteoporosis	4.21e-05	0.000171	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ATIC—osteoporosis	4.16e-05	0.000169	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PNP—osteoporosis	4.16e-05	0.000169	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—MYC—osteoporosis	4.14e-05	0.000168	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—MYC—osteoporosis	4.06e-05	0.000165	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TGFB1—osteoporosis	3.96e-05	0.00016	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—ESR1—osteoporosis	3.9e-05	0.000158	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—MYC—osteoporosis	3.89e-05	0.000158	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—MYC—osteoporosis	3.89e-05	0.000158	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ADCY5—osteoporosis	3.71e-05	0.00015	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GPX1—osteoporosis	3.7e-05	0.00015	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TNF—osteoporosis	3.69e-05	0.00015	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—IDH2—osteoporosis	3.67e-05	0.000149	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—OXCT1—osteoporosis	3.54e-05	0.000143	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CA2—osteoporosis	3.54e-05	0.000143	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP27A1—osteoporosis	3.45e-05	0.00014	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—MGLL—osteoporosis	3.45e-05	0.00014	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—MTHFR—osteoporosis	3.41e-05	0.000138	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	3.39e-05	0.000137	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	3.38e-05	0.000137	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ACP5—osteoporosis	3.36e-05	0.000136	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.25e-05	0.000132	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.17e-05	0.000128	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	3.16e-05	0.000128	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—TPI1—osteoporosis	3.12e-05	0.000127	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—IL6—osteoporosis	2.98e-05	0.000121	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—P4HB—osteoporosis	2.94e-05	0.000119	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—IDH2—osteoporosis	2.93e-05	0.000119	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GAPDH—osteoporosis	2.88e-05	0.000117	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—RAP1A—osteoporosis	2.81e-05	0.000114	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP27A1—osteoporosis	2.76e-05	0.000112	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—POMC—osteoporosis	2.73e-05	0.000111	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ACP5—osteoporosis	2.68e-05	0.000109	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.65e-05	0.000107	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—TPI1—osteoporosis	2.49e-05	0.000101	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—P4HB—osteoporosis	2.35e-05	9.5e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GAPDH—osteoporosis	2.3e-05	9.33e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ENO1—osteoporosis	2.27e-05	9.2e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—RAP1A—osteoporosis	2.24e-05	9.08e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PSMA2—osteoporosis	2.24e-05	9.06e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PSMA5—osteoporosis	2.24e-05	9.06e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—MYC—osteoporosis	2.03e-05	8.22e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.96e-05	7.92e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP19A1—osteoporosis	1.81e-05	7.35e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ENO1—osteoporosis	1.81e-05	7.34e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PSMA2—osteoporosis	1.79e-05	7.24e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PSMA5—osteoporosis	1.79e-05	7.24e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ADCY5—osteoporosis	1.48e-05	6.01e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GPX1—osteoporosis	1.48e-05	5.99e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP19A1—osteoporosis	1.45e-05	5.87e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—MTHFR—osteoporosis	1.36e-05	5.53e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ADCY5—osteoporosis	1.18e-05	4.8e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GPX1—osteoporosis	1.18e-05	4.78e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—POMC—osteoporosis	1.09e-05	4.42e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—MTHFR—osteoporosis	1.09e-05	4.41e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—POMC—osteoporosis	8.71e-06	3.53e-05	CbGpPWpGaD
